Sangamo Therapeutics, Inc. (SGMO): Price and Financial Metrics

Sangamo Therapeutics, Inc. (SGMO): $0.44

0.01 (+2.95%)

POWR Rating

Component Grades








Add SGMO to Watchlist
Sign Up

Industry: Biotech




#303 of 353

in industry

SGMO Price/Volume Stats

Current price $0.44 52-week high $3.76
Prev. close $0.43 52-week low $0.29
Day low $0.43 Volume 697,757
Day high $0.47 Avg. volume 2,013,448
50-day MA $0.49 Dividend yield N/A
200-day MA $1.23 Market Cap 78.51M

SGMO Stock Price Chart Interactive Chart >


  • SGMO scores best on the Value dimension, with a Value rank ahead of 71.09% of US stocks.
  • SGMO's strongest trending metric is Growth; it's been moving down over the last 170 days.
  • SGMO ranks lowest in Quality; there it ranks in the 3rd percentile.

SGMO Stock Summary

  • Of note is the ratio of SANGAMO THERAPEUTICS INC's sales and general administrative expense to its total operating expenses; just 4.66% of US stocks have a lower such ratio.
  • As for revenue growth, note that SGMO's revenue has grown 79.75% over the past 12 months; that beats the revenue growth of 94.02% of US companies in our set.
  • In terms of volatility of its share price, SGMO is more volatile than 93.27% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to SANGAMO THERAPEUTICS INC, a group of peers worth examining would be PTCT, HYMC, TSHA, IDR, and CRUS.
  • SGMO's SEC filings can be seen here. And to visit SANGAMO THERAPEUTICS INC's official web site, go to

SGMO Valuation Summary

  • SGMO's price/earnings ratio is -0.3; this is 101.23% lower than that of the median Healthcare stock.
  • Over the past 243 months, SGMO's price/earnings ratio has gone up 12.6.

Below are key valuation metrics over time for SGMO.

Stock Date P/S P/B P/E EV/EBIT
SGMO 2023-11-03 0.4 0.6 -0.3 -0.2
SGMO 2023-11-02 0.4 0.6 -0.3 -0.2
SGMO 2023-11-01 0.5 0.8 -0.4 -0.3
SGMO 2023-10-31 0.5 0.5 -0.6 -0.4
SGMO 2023-10-30 0.4 0.4 -0.5 -0.3
SGMO 2023-10-27 0.4 0.4 -0.4 -0.2

SGMO Growth Metrics

    The 3 year net cashflow from operations growth rate now stands at -2300.02%.
  • Its 2 year net cashflow from operations growth rate is now at -89.28%.
  • The 4 year price growth rate now stands at 108.28%.
Over the past 52 months, SGMO's revenue has gone up $40,607,000.

The table below shows SGMO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 111.299 -223.627 -192.278
2022-09-30 112.055 -219.292 -177.801
2022-06-30 114.158 -225.094 -172.334
2022-03-31 112.652 -223.676 -176.33
2021-12-31 110.701 -233.251 -178.286
2021-09-30 108.515 -184.832 -181.394

SGMO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SGMO has a Quality Grade of C, ranking ahead of 46.27% of graded US stocks.
  • SGMO's asset turnover comes in at 0.127 -- ranking 244th of 682 Pharmaceutical Products stocks.
  • ALBO, LXRX, and ATNX are the stocks whose asset turnover ratios are most correlated with SGMO.

The table below shows SGMO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.127 1 -0.356
2021-06-30 0.152 1 -0.251
2021-03-31 0.143 1 -0.252
2020-12-31 0.140 1 -0.270
2020-09-30 0.191 1 -0.186
2020-06-30 0.162 1 -0.272

SGMO Price Target

For more insight on analysts targets of SGMO, see our SGMO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $20.67 Average Broker Recommendation 1.55 (Moderate Buy)

Sangamo Therapeutics, Inc. (SGMO) Company Bio

Sangamo Therapeutics, Inc., a clinical stage biopharmaceutical company, focused on the research, development, and commercialization of engineered DNA-binding proteins as novel therapeutic products for various monogenic and infectious diseases with unmet medical needs. The company was founded in 1995 and is based in Richmond, California.

SGMO Latest News Stream

Event/Time News Detail
Loading, please wait...

SGMO Latest Social Stream

Loading social stream, please wait...

View Full SGMO Social Stream

Latest SGMO News From Around the Web

Below are the latest news stories about SANGAMO THERAPEUTICS INC that investors may wish to consider to help them evaluate SGMO as an investment opportunity.

Companies Like Sangamo Therapeutics (NASDAQ:SGMO) Could Be Quite Risky

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Yahoo | November 21, 2023

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q3 2023 Earnings Call Transcript

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q3 2023 Earnings Call Transcript November 2, 2023 Operator: Good morning, and thank you for standing by. Welcome to the Sangamo Third Quarter 2023 Teleconference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised […]

Yahoo | November 3, 2023

Sangamo to cut jobs again with planned business overhaul

The gene therapy company will move headquarters and reduce its workforce by 40%, while seeking partners for its Fabry and cell therapy research.

Yahoo | November 2, 2023

Sangamo Therapeutics Inc (SGMO) Announces Q3 2023 Financial Results and Strategic Update

Company focuses on neurology-focused genomic medicine, announces restructuring and workforce reduction

Yahoo | November 1, 2023

Sangamo Therapeutics Announces Strategic Update and Reports Third Quarter 2023 Financial Results


Yahoo | November 1, 2023

Read More 'SGMO' Stories Here

SGMO Price Returns

1-mo -25.52%
3-mo -55.22%
6-mo -61.74%
1-year -87.64%
3-year -95.64%
5-year -96.44%
YTD -85.99%
2022 -58.13%
2021 -51.94%
2020 86.44%
2019 -27.09%
2018 -30.00%

Continue Researching SGMO

Want to see what other sources are saying about Sangamo Therapeutics Inc's financials and stock price? Try the links below:

Sangamo Therapeutics Inc (SGMO) Stock Price | Nasdaq
Sangamo Therapeutics Inc (SGMO) Stock Quote, History and News - Yahoo Finance
Sangamo Therapeutics Inc (SGMO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!